FELIWAY SPRAY ANALOGUE OF FELINE FACIAL PHEROMONES Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

feliway spray analogue of feline facial pheromones

ceva animal health pty ltd - synthetic analogue of f3 fraction feline facial pheromon - topical pump spray - synthetic analogue of f3 fraction feline facial pheromon biological-pheromone active 100.0 mg/ml - miscellaneous veterinary - cat | kitten | cat - queen | cat - tom | kitten | young cat - stress | urine spray | eliminate urine spraying

FELIWAY DIFFUSER ANALOGUE OF FELINE FACIAL PHEROMONE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

feliway diffuser analogue of feline facial pheromone

ceva animal health pty ltd - synthetic analogue of f3 fraction feline facial pheromon - vet * - synthetic analogue of f3 fraction feline facial pheromon biological-pheromone active 16.5 mg/ml - central nervous system - cat | kitten | cat - queen | cat - tom | kitten | young cat - stress

Zycia Natal Nutrients Australia - English - Department of Health (Therapeutic Goods Administration)

zycia natal nutrients

zycia pty ltd - iron amino acid chelate, quantity: 80 mg (equivalent: iron, qty 8 mg); pyridoxal 5-phosphate monohydrate, quantity: 15 mg (equivalent: pyridoxine, qty 9.57 mg); mecobalamin, quantity: 500 microgram; calcium citrate tetrahydrate, quantity: 237.2 mg (equivalent: calcium, qty 50 mg); riboflavin, quantity: 25 mg; biotin, quantity: 150 microgram; potassium iodide, quantity: 288 microgram (equivalent: iodine, qty 220 microgram); nicotinamide, quantity: 25 mg; thiamine hydrochloride, quantity: 25 mg; pyridoxine hydrochloride, quantity: 25 mg (equivalent: pyridoxine, qty 20.56 mg); d-alpha-tocopheryl acid succinate, quantity: 10 mg; nicotinic acid, quantity: 5 mg; choline bitartrate, quantity: 300 mg; calcium folinate, quantity: 325.7 microgram (equivalent: folinic acid, qty 300 microgram); calcium pantothenate, quantity: 10 mg; ascorbic acid, quantity: 50 mg; inositol, quantity: 7.5 mg; folic acid, quantity: 200 microgram; sodium selenite, quantity: 0.088 mg (equivalent: selenium, qty 40 microgram); manganese amino acid chelate, quantity: 10 mg (equivalent: manganese, qty 1 mg); colecalciferol, quantity: 25 microgram; magnesium amino acid chelate, quantity: 125 mg (equivalent: magnesium, qty 25 mg); zinc citrate dihydrate, quantity: 32.1 mg (equivalent: zinc, qty 10 mg) - tablet, film coated - excipient ingredients: potable water; calcium phosphate; crospovidone; magnesium stearate; dl-alpha-tocopherol; croscarmellose sodium; sucrose; maize starch; carnauba wax; povidone; colloidal anhydrous silica; medium chain triglycerides; stearic acid; acacia; calcium hydrogen phosphate dihydrate; hypromellose; microcrystalline cellulose; titanium dioxide; indigo carmine; purified talc; polyvinyl alcohol; macrogol 3000; lecithin - antioxidant/reduce free radicals formed in the body ; maintain/support healthy growth and development ; maintain/support general health and wellbeing ; maintains/support healthy foetal development ; maintain/support healthy pregnancy ; maintain/support maternal health ; maintain/support preconception health ; helps prepare the body for pregnancy ; maintain/support healthy reproductive hormones

Craniofacial bone screw, non-biodegradable Australia - English - Department of Health (Therapeutic Goods Administration)

craniofacial bone screw, non-biodegradable

life healthcare pty ltd - 46638 - craniofacial bone screw, non-biodegradable - craniofacial bone screws are intended for surgical procedures requiring internal fixation by means of implants for the alignment, reconstruction and stabilization of bone tissue.

Craniofacial bone distractor extension Australia - English - Department of Health (Therapeutic Goods Administration)

craniofacial bone distractor extension

johnson & johnson medical pty ltd t/a depuy synthes - 47636 - craniofacial bone distractor extension - a temporary, partially-implantable device that is used as an extension to a craniofacial distractor. the extension moves the point of activation of the distractor to an area that is more easily accessible by the activation instrument. it is available in a range of lengths and may be rigid or flexible in design.